|
Orthovita, Inc. - Comparative Business Analysis Snapshot
Business Description
Orthovita, Inc.. The Group's principal activity is to develop, manufacture and market synthetic bone substitutes for orthopaedic applications that are useful in spine and joint replacements. The Group develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of osteoporotic fractures, and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets. The products are based on two platforms: The products include VITOSS Bone Graft Substitute technology platforms, which are designed to address the non-structural, bone-graft market and VITAGEL Surgical Hemostat, which is a matrix for soft-tissue healing.
Competitor Analysis
This analysis compares Orthovita, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
